homocysteine and s 1033

homocysteine has been researched along with s 1033 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balsat, M; Bert, A; Blond, E; Drai, J; Escoffre-Barbe, M; Etienne, G; Etienne, M; Fossard, G; Giraudier, S; Heiblig, M; Labussière-Wallet, H; Lega, JC; Mahon, FX; Morisset, S; Nicolini, FE; Redonnet-Vernhet, I; Sobh, M1

Other Studies

1 other study(ies) available for homocysteine and s 1033

ArticleYear
Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients.
    Haematologica, 2016, Volume: 101, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cholesterol, HDL; Coronary Artery Disease; Drug Administration Schedule; Female; Homocysteine; Humans; Hyperhomocysteinemia; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prospective Studies; Pyrimidines; Retrospective Studies; Triglycerides

2016
chemdatabank.com